Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

NCT05917106 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT05917106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05917106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Lead sponsor
Jinling Hospital, China
Phase
Observational
Overall status
Recruiting
Start date
December 26, 2022
Completion date
June 30, 2030
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, kidney cancer, kidney neoplasms, rcc, renal cell carcinoma